The only variable that improved prediction above and beyond episodic memory testing using two measures was APOE status, consistent with previous research recognizing APOE ε4-positive status as a major risk factor for subsequent AD (see [32] for a review). This evidence concerns the gene APOE and Alzheimer disease.